This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovator Shuhei Umemura: Pioneering KDM5 Inhibitory Compounds for Therapeutic Applications
Introduction: Shuhei Umemura is a prominent inventor based in Osaka, Japan, known for his significant contributions to pharmaceutical technology. With a remarkable career at Ono Pharmaceutical Co., Ltd., Umemura has focused his research on developing compounds that target KDM5 inhibitory activity, which has vital implications for treating various diseases.
Latest Patents: Umemura holds two notable patents that reveal groundbreaking work in his field. Both patents detail compounds with KDM5 inhibitory activity, aimed at serving as prophylactic and therapeutic agents for serious conditions such as cancer, Huntington's disease, and Alzheimer's disease. The patents disclose compounds represented by a specific formula, where all symbols are defined according to their specifications. These innovations showcase Umemura's commitment to advancing treatment options for debilitating health issues.
Career Highlights: Throughout his career, Shuhei Umemura has demonstrated not only outstanding scientific acumen but also an impressive dedication to pharmaceutical research. His tenure at Ono Pharmaceutical Co., Ltd. has allowed him to participate in cutting-edge projects that seek to address critical medical challenges through innovative solutions.
Collaborations: In the realm of research and development, Umemura has collaborated with esteemed colleagues, including Akito Kakuuchi and Masaki Asada. These collaborations highlight the importance of teamwork in driving innovation and fostering the development of new therapeutic agents.
Conclusion: In conclusion, Shuhei Umemura stands out as an influential inventor, with his work on KDM5 inhibitory compounds marking a significant contribution to the field of pharmaceuticals. His innovative spirit and commitment to enhancing human health continue to shape the future of therapeutic applications. As research progresses, Umemura's discoveries may hold the key to more effective treatments for patients suffering from critical diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile